BMY - BRISTOL MYERS SQUIBB CO


60.74
-1.590   -2.618%

Share volume: 14,713,464
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.31%

PREVIOUS CLOSE
CHG
CHG%

$62.33
-1.59
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 04-25-2024 07-26-2024 10-31-2024 02-12-2025 04-24-2025 07-31-2025 10-30-2025 02-11-2026
Cash flow financing 14.644 B -4.023 B -3.852 B -1.642 B -993.000 M -1.836 B -1.490 B -6.029 B
Other financing cash flows -97.000 M -6.000 M 16.000 M -19.000 M -103.000 M 11.000 M -3.000 M -33.000 M
Cash flow -2.140 B -3.016 B 1.520 B 2.601 B 462.000 M 1.608 B 3.119 B -5.513 B
Net income -11.908 B 1.684 B 1.215 B 76.000 M 2.462 B 1.313 B 2.195 B 1.085 B
Depreciation 2.532 B 2.596 B 2.592 B 1.880 B 1.012 B 1.011 B 1.011 B 977.000 M
Changes in inventories 218.000 M 0.000 0.000 0.000 169.000 M 0.000 0.000 0.000
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -19.618 B -1.319 B -219.000 M -196.000 M -499.000 M -473.000 M -1.702 B -1.458 B
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Dividends Paid -1.212 B -1.217 B -1.216 B -1.218 B -1.258 B -1.262 B -1.263 B -1.262 B
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 284.000 M 262.000 M 324.000 M 378.000 M 260.000 M 361.000 M 320.000 M 370.000 M
Cash Change -2.185 B -3.038 B 1.597 B 2.454 B 528.000 M 1.736 B 3.115 B -5.508 B